Advocacy intelligence hub — real-time data for patient organizations
National Cancer Institute (NCI) — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Elitek
(rasburicase)Orphan drugstandardSanofi-Synthelabo Research
12.1 Mechanism of Action In humans, uric acid is the final step in the catabolic pathway of purines. Rasburicase catalyzes enzymatic oxidation of poor...
Richard E Champlin
M D Anderson Cancer Center
📍 Houston, Texas
B. Smith, M.S.W., L.C.S.W
Johns Hopkins University
📍 OKLAHOMA CITY, OK
Kyoo H. Lee, MD
Asan Medical Center
Véronique Gelsi-Boyer, MD
Institut Paoli-Calmettes
Judith Karp, M.D
Johns Hopkins University/Sidney Kimmel Cancer Center
📍 BALTIMORE, MD
Paolo Caimi, MD, M.D
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
📍 CLEVELAND, OH